Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Currarino syndrome (CS) is an autosomal dominant congenital disorder defined by the triad of partial sacral agenesis, anorectal malformation, and presacral mass. MNX1 encodes a homeobox transcription factor essential for caudal embryonic development. Pathogenic variants in MNX1 associate with CS, guiding diagnostic evaluation in individuals presenting with one or more triad features (PMID:10749657).
Extensive mutation surveys identified intragenic MNX1 mutations in 20 of 21 familial CS index patients and in 2 of 7 sporadic cases (PMID:10749657). A multicentre study of 50 CS probands reported 23 novel MNX1 heterozygous mutations in 26 patients, yielding a detection rate of ~90% in familial settings (PMID:18449898). These data support a Definitive gene–disease relationship.
Inheritance is autosomal dominant with variable penetrance. Segregation analysis in a Swedish family revealed that 3 additional brothers carrying a frameshift MNX1 variant developed presacral tumors—two asymptomatic—underscoring intrafamilial variability (PMID:21763840).
The MNX1 variant spectrum includes frameshift (e.g., c.196_211del (p.Pro66fs)), nonsense (e.g., c.863G>A (p.Trp288Ter)), missense, polyalanine expansions, and whole-gene deletions. A GCC12 polyalanine allele (c.373_375[12]) represents a benign variant, highlighting the need for dosage analysis when sequencing is uninformative (PMID:23370340).
Functional and expression studies corroborate haploinsufficiency as the pathogenic mechanism. MNX1 is expressed in the human basal spinal cord and pancreas during Carnegie stages 12–21. Homeodomain mutations alter DNA-binding and nuclear localization, matching the clinical spectrum (PMID:10749657).
In summary, the evidence meets ClinGen Definitive criteria. MNX1 testing is recommended for patients with anorectal anomalies, hemisacrum, or presacral masses to confirm CS, inform surveillance strategies, and enable genetic counseling.
Gene–Disease AssociationDefinitiveIdentified in 20 of 21 familial and multiple sporadic cases; extensive segregation and functional concordance Genetic EvidenceStrong22 index cases with intragenic mutations; segregation in 3 relatives; diverse LoF and missense variants ([PMID:10749657], [PMID:21763840]) Functional EvidenceModerateExpression during key developmental stages; homeodomain mutations impair DNA binding and localization ([PMID:10749657]) |